Submissions from 2024
Polyvagal theory for kids: A brain-based teaching tool to promote coping, Katy Tenhulzen
Non-immune hydrops fetalis is associated with bi-allelic pathogenic variants in the MYB Binding Protein 1a (MYBBP1A) gene., Jair Tenorio-Castano, Elena Mansilla Aparicio, Fe Amalia García Santiago, Cherise M Klotz, Rita María Regojo, Estefanía Anguita, Erin Ryan, Jane Juusola, Beatriz Herrero, Pedro Arias, Alejandro Parra, Patricia Pascual, Natalia Gallego, Mario Cazalla, Roberto Rodriguez-González, Eugenia Antolín, Julián Nevado, Víctor L Ruiz-Perez, and Pablo Lapunzina
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today., Howard Trachtman, Hailey Desmond, Amanda L Williams, Laura H Mariani, Sean Eddy, Wenjun Ju, Laura Barisoni, Heather K Ascani, Wendy R Uhlmann, Cathie Spino, Lawrence B Holzman, John R Sedor, Crystal Gadegbeku, Lalita Subramanian, Chrysta C Lienczewski, Tina Manieri, Scott J Roberts, Debbie S Gipson, Matthias Kretzler, NEPTUNE investigators, and Katherine Tuttle (NEPTUNE investigators)
Past, Present, and Future of Cellular Immunotherapy, Eric Tran
Erratum to “Sammie Mosier, DHA, MA, BSN, NE-BC” [Nurse Leader 22/5 (2024) 491-495], Sylvain Trepanier
Leader To Watch: Sammie Mosier, DHA, MA, BSN, NE-BC, Sylvain Trepanier
Safe Staffing Through New Models of Care, Sylvain Trepanier, Kathleen Sanford, Gay Landstrom, Rosalie Mainous, and Susan Bakewell-Sachs
Safe Staffing Through New Models of Care, Sylvain Trepanier, Kathleen Sanford, Gay Landstrom, Rosalie Mainous, and Susan Bakewell-Sachs
Safety of Ketamine Use for Rapid Control of Agitation in the Emergency Department, Rosa Hong Trieu
Second Malignant Neoplasms Following Treatment for Hepatoblastoma: An International Report and Review of the Literature., Angela Trobaugh-Lotrario, Kenichiro Watanabe, Allison F O'Neill, Bozenna Dembowska-Bagińska, Beate Häberle, Andrew Murphy, Eiso Hiyama, Piotr Czauderna, Rebecka L Meyers, Max Langham, and James Feusner
Journal names its 25 People of Influence in 2025, Katherine Tuttle (author mention)
379. SGLT Inhibitors: The Biology of SGLT Inhibition with Dr. Katherine Tuttle, Katherine Tuttle
“Adjunctive Therapy in T1D”, Katherine Tuttle
“A Pinch of Salt – A Podcast by ERA”, Katherine Tuttle
“Benefits of Semaglutide on Chronic Kidney Disease Outcomes by Cardiovascular Status of Risk in the FLOW Trial.", Katherine Tuttle
“Benefits of semaglutide on chronic kidney disease outcomes by cardiovascular status or risk in the FLOW trial.", Katherine Tuttle
“Building your academic career portfolio”, Katherine Tuttle
“Cardiovascular-Kidney-Metabolic Syndrome, Katherine Tuttle
CKD screening for better kidney health: Why? Who? How? When?, Katherine Tuttle
Clinical and Mechanistic Effects of GLP-1 Receptor Agonists in CKD, Katherine Tuttle
“Diabetic Nephropathy 2024: Comprehensive Care for People with Diabetes Mellitus and Advanced Chronic Kidney Disease.", Katherine Tuttle
“Effects of Semaglutide on CKD in Patients with Type 2 Diabetes (FLOW)”, Katherine Tuttle
“Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.”, Katherine Tuttle
“FLOW: A new treatment paradigm for people with T2D and chronic kidney disease”, Katherine Tuttle
“FLOW: Benefits of Semaglutide on CKD by Cardiovascular Status or Risk.”, Katherine Tuttle
“FLOW Result: Summary and Clinical Implication, Katherine Tuttle
“FLOW: Semaglutide scores big in diabetic patients with CKD”, Katherine Tuttle
“ GLP1-RA in CKD”, Katherine Tuttle
GLP-1 Receptor Agonists for CKD in Diabetes and Beyond…, Katherine Tuttle
“GLP-1 Receptor Agonists for CKD in Diabetics and Beyond”, Katherine Tuttle
“Going with the FLOW: Understanding the renal effects of GLP-1RA Therapy”, Katherine Tuttle
Helio “Aldosterone inhibitor BI 690517 reduced albuminuria when combined with SGLT2 inhibitor”, Katherine Tuttle
Horizons-EASD eLearning, Katherine Tuttle
“How GLP1 receptor agonist evolved from weight management drug to kidney protective therapy”, Katherine Tuttle
“How Will the Incretin Data “FLOW” into Practice?”, Katherine Tuttle
“ Key considerations for tailoring treatment approaches for diabetic patients with chronic kidney disease", Katherine Tuttle
“Kidney Compass Podcast with Drs. Neuen/Wadhwani & Tuttle, Katherine Tuttle
“Kidney Disease and Obesity”, Katherine Tuttle
“Kidney Health for All: Advancing equitable access to care and optimal medication practice”, Katherine Tuttle
“Kidney Week 2024 Press Conference”, Katherine Tuttle
“Kidney Week 2024 Video Interview”, Katherine Tuttle
“Landmark studies”, Katherine Tuttle
“Miracle weight-loss drugs could halt kidney disease too”, Katherine Tuttle
“Navigating the Sea Change of CKD Treatment in Diabetes”, Katherine Tuttle
“Nephrology Times Interview”, Katherine Tuttle
“New study shows Ozempic lowers kidney disease”, Katherine Tuttle
“New use for Ozempic”, Katherine Tuttle
“Ozempic cuts risk in kidney disease”, Katherine Tuttle
“Ozempic cuts risk of chronic kidney disease complications, study finds””, Katherine Tuttle
“Ozempic keeps wowing: trial data show benefits for kidney disease”, Katherine Tuttle
“Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds", Katherine Tuttle
Plenary - “Kidney Health and CKD Prevention Herald a Sea Change in Nephrology”, Katherine Tuttle
Research Development., Katherine Tuttle
“Sea Change in CKD”, Katherine Tuttle
“Semaglutide cuts kidney failure and death in diabetes”, Katherine Tuttle
“Semaglutide Reduced Risks of Major Kidney Outcomes Irrespective of CKD Severity in the FLOW Trial”, Katherine Tuttle
“Semaglutide significantly improves chronic kidney disease”, Katherine Tuttle
“State-of-are Treatment for DKD”, Katherine Tuttle
“State of the art treatment for CKD”, Katherine Tuttle
“Study crystallizes distinct kidney benefits of common drug”, Katherine Tuttle
“Success of GLP-1 receptor agonists in kidney disease halts FLOW trial early.”, Katherine Tuttle
Talk with a Doc Podcast, Katherine Tuttle
The FLOW Trial of Semaglutide for CKD in Type 2 Diabetes: Kidney, Cardiovascular, and Mortality Outcomes, Katherine Tuttle
“The Next Stage: CKM Syndrome Progression and Implications for CVD Outcomes”, Katherine Tuttle
“Therapeutic Transformation of Chronic Kidney Disease”, Katherine Tuttle
“Transforming CKD Care from Evidence Generation to Implementation”, Katherine Tuttle
Transforming CKD Care from Evidence Generation to Implementation, Katherine Tuttle
“Transforming Kidney Care – Breakthrough Therapies”, Katherine Tuttle
Treatment of Chronic Kidney Disease and Heart Failure Circa 2024, Katherine Tuttle
“Why diabetes miracle drugs like Ozempic are off-limits to Type 1s”, Katherine Tuttle
Clinical Characteristics and Histopathology in Adults With Focal Segmental Glomerulosclerosis., Katherine Tuttle, Clint W Abner, Patrick D Walker, Kaijun Wang, Andrew Rava, Jihaeng Heo, and Martin Bunke
Clinical Characteristics and Histopathology in Adults With Focal Segmental Glomerulosclerosis., Katherine Tuttle, Clint W Abner, Patrick D Walker, Kaijun Wang, Andrew Rava, Jihaeng Heo, and Martin Bunke
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial., Katherine Tuttle, Sibylle J Hauske, Maria Eugenia Canziani, Maria Luiza Caramori, David Cherney, Lisa Cronin, Hiddo J L Heerspink, Christian Hugo, Masaomi Nangaku, Ricardo Correa Rotter, Arnold Silva, Shimoli V Shah, Zhichao Sun, Dorothea Urbach, Dick de Zeeuw, and Peter Rossing
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial., Katherine R Tuttle, Sibylle J Hauske, Maria Eugenia Canziani, Maria Luiza Caramori, David Cherney, Lisa Cronin, Hiddo J L Heerspink, Christian Hugo, Masaomi Nangaku, Ricardo Correa Rotter, Arnold Silva, Shimoli V Shah, Zhichao Sun, Dorothea Urbach, Dick de Zeeuw, Peter Rossing, and ASi in CKD group
Anal Condyloma and Human Papillomavirus: Recognition, Treatment, and Prevention., Kenley R Unruh and Debra D Lai
Left atrial to coronary sinus shunting for treatment of heart failure with mildly reduced or preserved ejection fraction: The ALT FLOW Early Feasibility Study 1-year results., Marcus A Urey, Benjamin Hibbert, Ulrich Jorde, Peter Eckman, Trevor Simard, Marino Labinaz, Babak Nazer, Mark Wiley, Bhanu Gupta, Andrew Sauer, Hirak Shah, Paul Sorajja, Andres M Pineda, Emil Missov, Ehtisham Mahmud, Rami Kahwash, Scott Lilly, Azeem Latib, Sandhya Murthy, Neil Fam, Santiago Garcia, Eugene S Chung, Liviu Klein, Richard Cheng, Brian A Houston, Nicholas S Amoroso, Lee Chang, Sameer Gafoor, Sunit-Preet Chaudhry, James Hermiller, Jonathan G Schwartz, Lillian Aldaia, Konstantinos Koulogiannis, William A Gray, and Firas Zahr
Origin of biogeographically distinct ecotypes during laboratory evolution., Jacob J Valenzuela, Selva Rupa Christinal Immanuel, James Wilson, Serdar Turkarslan, Maryann Ruiz, Sean M Gibbons, Kristopher A Hunt, Nejc Stopnisek, Manfred Auer, Marcin Zemla, David A Stahl, and Nitin Baliga
Combination therapy for kidney disease in people with diabetes mellitus., Daniël H van Raalte, Petter Bjornstad, David Z I Cherney, Ian H de Boer, Paola Fioretto, Daniel Gordin, Frederik Persson, Sylvia E Rosas, Peter Rossing, Jennifer A Schaub, Katherine Tuttle, Sushrut S Waikar, and Hiddo J L Heerspink
The Zea mays PeptideAtlas: A New Maize Community Resource, Klaas J van Wijk, Tami Leppert, Zhi Sun, Isabell Guzchenko, Erica Debley, Georgia Sauermann, Pratyush Routray, Luis Mendoza, Qi Sun, and Eric W Deutsch
Detection of the Arabidopsis Proteome and Its Post-translational Modifications and the Nature of the Unobserved (Dark) Proteome in PeptideAtlas, Klaas J van Wijk, Tami Leppert, Zhi Sun, Alyssa Kearly, Margaret Li, Luis Mendoza, Isabell Guzchenko, Erica Debley, Georgia Sauermann, Pratyush Routray, Sagunya Malhotra, Andrew Nelson, Qi Sun, and Eric W Deutsch
A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice., Della Varghese, Giovanna I Cruz, Colden Johanson, Liz Toland, Miguel Miranda, Eleanor C Faherty, David Harland, and Henry G Kaplan
Management of Neurologic Complications in Patients with Brain and Spine Tumors., Alipi V Bonm and Lynne P Taylor
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials., Séverine Vermeire, Bruce E Sands, Laurent Peyrin-Biroulet, Geert R D'Haens, Julian Panés, Andres J Yarur, Douglas C Wolf, Timothy Ritter, Stefan Schreiber, John C Woolcott, Irene Modesto, Michael Keating, Kevin Shan, Joseph Wu, Michael Chiorean, Filip Baert, Marla C Dubinsky, Martina Goetsch, Silvio Danese, and Brian G Feagan
The Postoperative Airway Compromise Score-First Steps to Developing a Postoperative Tool for the Assessment of Upper Airway-Related Complications Following Anterior Cervical Spine Surgery., Alexander von Glinski, Clifford A Pierre, Christopher Elia, Basem Ishak, Periklis Godolias, Ronen Blecher, Joseph R Detorri, Daniel C Norvell, Luke Jouppi, Julius Gerstmeyer, Steven A Deem, J Blake Golden, Thomas A Schildhauer, Rod J Oskouian, and Jens R Chapman
Historical Perspectives on the Evolution of Spino-Pelvic Fixation and its Implications on Clinical Care A Narrative Review., Alexander von Glinski, Emre Yilmaz, Periklis Godolias, Lorin Benneker, F C Oner, Frank Kandziora, Gregory Schroeder, Klaus Schnake, Marcel Dvorak, Shanmuganathan Rajasekaran, Mohammad El-Sharkawi, Alexander Vaccaro, Richard Bransford, Thomas A Schildhauer, and Jens R Chapman
Ambulatory Robotic Colectomy: Factors Affecting and Affected by Postoperative Opioid Use., Michael M Vu, Jace J Franko, Anna Buzadzhi, Beau Prey, Maksim Rusev, Marta M Lavery, and Laila Rashidi
Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020., Michael J Wagner, Vinod Ravi, Stephanie K Schaub, Ed Y Kim, Jeremy Sharib, Harveshp Mogal, Min Park, Michaela Tsai, Daniela Duarte-Bateman, Anthony Tufaro, Elizabeth T Loggers, Lee D Cranmer, Bonny Chau, Michael J Hassett, Juneko Grilley-Olson, and Kelly G Paulson
Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors., Jessica A Walsh, Iris Lin, Ruizhi Zhao, Natalie J Shiff, Laura Morrison, Bruno Emond, Louise H Yu, Samuel Schwartzbein, Patrick Lefebvre, Dominic Pilon, Soumya D Chakravarty, and Philip Mease
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study., Chia-Shi Wang, Dorey A Glenn, Margaret Helmuth, Abigail R Smith, Andrew S Bomback, Pietro A Canetta, Gaia M Coppock, Myda Khalid, Katherine Tuttle, Raed Bou-Matar, Larry A Greenbaum, Bruce M Robinson, Lawrence B Holzman, William E Smoyer, Michelle N Rheault, Debbie Gipson, Laura H Mariani, and Cure Glomerulonephropathy (CureGN) Study Consortium
Global Spine Journal and Global Spine Congress., Jeffrey C Wang, Jens R Chapman, and Karsten Wiechert
Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison., Richard B Warren, Iain B McInnes, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Damon Willems, Vanessa Taieb, Jason Eells, and Philip Mease
Critical lessons from a pragmatic randomized trial of home-based COVID-19 testing in rural Native American and Latino communities., Eliza Webber, Sonia Bishop, Paul K Drain, Virgil Dupuis, Lorenzo Garza, Charlie Gregor, Laurie Hassell, Geno Ibarra, Larry Kessler, Linda Ko, Alison Lambert, Victoria Lyon, Carly Rowe, Michael Singleton, Matthew Thompson, Teresa Warne, Wendy Westbroek, and Alexandra Adams
A parallel-group randomized controlled trial of blue light versus red light for improving sleep, fatigue, and cognition following stroke: Pilot results and recommendations for further study., Douglas L Weeks, Elena Crooks, Katie E O'Brien, Gina Sprint, Gregory T Carter, and Kimberly A Honn
Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system., Qi Wei, Philip J Mease, Michael Chiorean, Lulu Iles-Shih, Wanessa F Matos, Andrew Baumgartner, Sevda Molani, Yeon Mi Hwang, Basazin Belhu, Alexandra Ralevski, and Jennifer Hadlock
Understanding Washington State's Low Uptake of Lung Cancer Screening in Two Steps: A Geospatial Analysis of Patient Travel Time and Health Care Availability of Imaging Sites., Allison C Welch, Jed A Gorden, Stephen J Mooney, Candice L Wilshire, and Steven B Zeliadt
When Will Peer-Review Become A.I.-Review?, Karsten Wiechert, Jeffrey C Wang, and Jens R Chapman
Unhealthy Alcohol Use and Initiation of and Adherence to Pre-Exposure Prophylaxis Among Va Patients: Overall and Among Sexual and Gender Minoritized Patients Veterans, EC Williams, K McGinnis, M Skanderson, EJ Austin, M Bentley, JL Goulet, D Satre, Kara M. Bensley, K Bryant, and EJ Edelman
Persistent Lower Extremity Compensation for Sagittal Imbalance After Surgical Correction of Complex Adult Spinal Deformity: A Radiographic Analysis of Early Impact., Tyler K Williamson, Pooja Dave, Jamshaid M Mir, Justin S Smith, Renaud Lafage, Breton Line, Bassel G Diebo, Alan H Daniels, Jeffrey L Gum, Themistocles S Protopsaltis, D Kojo Hamilton, Alex Soroceanu, Justin K Scheer, Robert Eastlack, Michael P Kelly, Pierce Nunley, Khaled M Kebaish, Stephen Lewis, Lawrence G Lenke, Richard A Hostin, Munish C Gupta, Han Jo Kim, Christopher P Ames, Robert A Hart, Douglas C Burton, Christopher I Shaffrey, Eric O Klineberg, Frank J Schwab, Virginie Lafage, Dean Chou, Kai-Ming Fu, Shay Bess, Peter G Passias, and International Spine Study Group
Perspectives on Online Resources for People Experiencing Pain: A Qualitative Study., Marian Wilson, Janet R Katz, Mafe D Chase, Ross J Bindler, Teresa L Rangel, Rebecca A Penders, Pamela S Kohlmeier, and Jamie Lewis
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With, Francis P Worden, Evan Pisick, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Maged F Khalil, Daniel R Carrizosa, Jessica R Bauman, Rom Leidner, Herbert L Duvivier, Siqing Fu, Min Park, Kathleen J Yost, Carmen J Calfa, Alissa S Marr, Ani S Balmanoukian, Deepti Behl, Timothy L Cannon, Lisle Nabell, Steven Francis Powell, Ramya Thota, Dominique C Hinshaw, Abigail Gregory, Gina N Grantham, Susan Halabi, and Richard L Schilsky
